37 /100
MEDIUM RISK
Score updated Jul 13, 2026

BIOX — Bioceres Crop Solutions Corp. Dilution Risk Tracker

Track BIOX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BIOX — Get alerts when the score changes →

As of July 13, 2026, Bioceres Crop Solutions Corp. (BIOX) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. Bioceres Crop Solutions Corp. has a market capitalization of $28.46M, 63.23M shares outstanding, 34 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.49 below $1 exchange minimum
🔔 Track BIOX — Get forecast alerts →

💹 Market Data

Market Cap$28.46M
Shares Outstanding63.23M
Float43.66M
Cash$14.90M
Debt$240.00M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 32.6% shares (2026Q1 vs prior)
34 institutional holders · 9.39M shares
#1 Solel Partners LP 4.58M shares
#2 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 1.07M shares
#3 Long Focus Capital Management, LLC 829.7K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest920.2K
Days to Cover2.8
% of Float2.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for BIOX Shareholders

Bioceres Crop Solutions Corp. (BIOX) has a DilutionScore of 37/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for BIOX shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BIOX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BIOX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BIOX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BIOX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BIOX
📊 BIOX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BIOX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.